Anthem Biosciences Limited (BOM:544449)
India · Delayed Price · Currency is INR 889.55
+37.60 (4.41%)
At close: Oct 6, 2026
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 499.58 billion as of October 7, 2026. Its market cap has increased by 17.16% in one year.
Market Cap
499.58B
Enterprise Value
490.74B
Revenue
20.07B
Global Rank
n/a
Country Rank
n/a
PE Ratio
86.74
ChartMarket Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 499.58B, an increase of 21.80%. That is a compound annual growth rate of 17.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 501.44B | 37.05% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 601.00B |
| Anthem Biosciences | 501.44B |
| OneSource Specialty Pharma | 176.12B |
| Concord Biotech | 141.85B |
| Blue Jet Healthcare | 101.86B |
| Supriya Lifescience | 73.67B |
| Zota Health Care | 44.28B |
| Dishman Carbogen Amcis | 23.75B |